ask="0.639"
ask_size="100"
average_daily_volume="779387"
bid="0.630"
bid_size="500"
book_value="0.813"
change="+0.045"
change_from_200_day_moving_average="0.023"
change_from_50_day_moving_average="0.134"
change_from_52_week_high="-0.785"
change_From_52_week_low="0.304"
change_in_percent="+7.627%"
close="0.635"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.535"
ebitda="-17.93M"
eps_estimate_current_year="-0.780"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.570"
ex_dividend_date="N/A"
float_shares="29657000"
high="0.670"
high_52_weeks="1.420"
last_trade_date="1/12/2017"
last_trade_price="0.635"
last_trade_size="200"
last_trade_time="3:59pm"
low="0.581"
low_52_weeks="0.331"
market_capitalization="19.06M"
moving_average_200_day="0.612"
moving_average_50_day="0.501"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.900"
open="0.600"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+3.805%"
percent_change_from_50_day_moving_average="+26.770%"
percent_change_from_52_week_high="-55.279%"
percent_change_from_52_week_low="+91.843%"
previous_close="0.590"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.726"
price_per_sales="1.598"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="1.220"
stock_exchange="NCM"
symbol="OGXI"
volume="604423"
weeks_range_52="0.331 - 1.420"
